ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > »ý¸í°øÇÐ > Á¦¾à
Generic and innovative drugs market in Ukraine 2014, Development forecasts for 2014-2019
¹ßÇà»ç PMR

¹ßÇàÀÏ 2014-08
ºÐ·® 100 pages
¼­ºñ½ºÇüÅ Report
ÆǸŰ¡°Ý

ÀμâÇϱâ

Explore key issues on the Ukrainian market for generic and innovative drugs.
Report forecasts market development, analyses regulatory changes to 2019.

Which are the most influential manufacturers of generic and innovative drugs for the Ukrainian market? What reimbursement policies will most likely influence this market in the near future? Which data exclusivity rules apply to the Ukrainian market for generic and innovative drugs? What is the current and forecast value of this market and its major segments? What are the forecasts for market conditions in Ukraine over the next six years?
Generic and innovative drugs market in Ukraine, development forecasts for 2014-2019 answers these questions along with many others. This publication, compiled by PMR¡¯s team of experienced professionals, offers business information for use in a variety of vital tasks, from evaluating growth prospects to building a more attractive product portfolio.
The report examines changes in the value of the market and major segments from 2009-2014, studies the market share of the Ukrainian pharmaceuticals market currently held by generic and innovative medicines and provides in depth forecasts for market growth and transformation in the years ahead.
The document scrutinises regulations that currently govern pricing and reimbursement of generic and innovative drugs in Ukraine, supplies VAT rates and describes the changes expected with regard to the establishment of the system of the reimbursement. It provides descriptions of the data exclusivity and patent expiration rules and offers analyses of the results of recent changes to industry regulations.
Profiles of top generic and innovative drug producers in Ukraine describe the size, earnings and prospects for each company. Best selling products in each category are named, and patient and physician preferences with regard to generic and innovative medicines are supplied.
Whether businesspeople involved in this industry need to review market regulations particular to Ukraine, check on reimbursement procedures and upcoming changes or estimate demand or growth potential of this market – they will find the informational support needed in this valuable document. It is a remarkable asset when taking business decisions with implications that reach far into the future, such as whether to launch a new business or add a new product line.
Generic and innovative drugs market in Ukraine, development forecasts for 2014-2019 is typically utilised by businesses assessing the market for possible entry, current producers and distributors of generic and innovative drugs for the Ukrainian market and a variety of investment and financial service professionals. Research and consulting professionals also avail themselves of its advantages, along with academic and government institutions, trade and commerce-oriented organizations and business consultants.
Purchase this report today and enjoy the benefits of a complete source of business information, analysis and forecasts contained in a single, easy to access document. Convenient, reliable and logically organised, it is a true time (and money) saver. Order your copy now!


ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.